MHP
INSM icon

Manatuck Hill Partners’s Insmed INSM Stock Holding History

Manatuck Hill Partners’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-146,761
Closed -$2.79M – 102
2014
Q1 		$2.79M Buy
146,761
+68,211
+87% +$1.3M 0.44% 49
2013
Q4 		$1.33M Sell
78,550
-244,850
-76% -$3.75M 0.19% 66
2013
Q3 		$5.05M Buy
+323,400
New +$4.11M 0.65% 43

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Manatuck Hill Partners's INSM Position: Q2 2014 in Review

Manatuck Hill Partners sold out of Insmed (INSM) in Q2 2014, closing a stake of 146,761 shares — an estimated $2.79M sold.

Manatuck Hill Partners first reported a position in INSM in Q3 2013 and held it in 3 quarters. The position peaked at $5.05M in Q3 2013. 103 funds tracked by Wall St. Rank hold INSM as of Q2 2014.

  • Manatuck Hill Partners reported no remaining Insmed position as of Q2 2014 after selling out during the quarter.
  • Manatuck Hill Partners sold 146,761 Insmed shares in Q2 2014, an estimated $2.79M.
  • Manatuck Hill Partners first reported a position in Insmed in Q3 2013 and held it in 3 quarters.
  • Manatuck Hill Partners's Insmed position peaked at $5.05M in Q3 2013.
  • 103 funds tracked by Wall St. Rank held Insmed as of Q2 2014.

Based on Manatuck Hill Partners's 13F filing for Q2 2014, filed 14 Aug 2014.